Am J Psychiatry

1. LIGHT GA, Swerdlow NR
   Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?
   Am J Psychiatry. 2024;181:272-274.
   

   >> Share

   
   

   
   Can J Psychiatry

2. CORONADO-MONTOYA S, Abdel-Baki A, Crockford D, Cote J, et al
   Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Preferences des jeunes adultes souffrant de psychose pour les interventions de reduction des mefaits axees sur le cannabis : une etu
   Can J Psychiatry. 2024 Apr 4:7067437241242395. doi: 10.1177/07067437241242395.
   

   >> Share

   
   

   
   J Psychiatry Neurosci

3. MIHALJEVIC M, Nagpal A, Etyemez S, Narita Z, et al
   Neuroimaging alterations and relapse in early-stage psychosis.
   J Psychiatry Neurosci. 2024;49:E135-E142.
   

   >> Share

   
   
4. DALTON K, Joober R, Karama S, Palaniyappan L, et al
   Making use of N-of-1 trials to treat ADHD in people with psychosis: a hypothetical case.
   J Psychiatry Neurosci. 2024;49:E133-E134.
   

   >> Share

   
   

   
   Psychiatry Res

5. HAMZEHPOUR L, Bohn T, Dutsch V, Jaspers L, et al
   From brain to body: exploring the connection between altered reward processing and physical fitness in schizophrenia.
   Psychiatry Res. 2024;335:115877.
   

   >> Share

   
   

   
   Psychol Med

6. DEMRO C, Lahud E, Burton PC, Purcell JR, et al
   Reward anticipation-related neural activation following cued reinforcement in adults with psychotic psychopathology and biological relatives.
   Psychol Med. 2024;54:1441-1451.
   

   >> Share

   
   
7. WANG J, Luo GY, Tian T, Zhao YQ, et al
   Shared genetic basis and causality between schizophrenia and inflammatory bowel disease: evidence from a comprehensive genetic analysis.
   Psychol Med. 2024 Apr 2:1-11. doi: 10.1017/S0033291724000771.
   

   >> Share

   
   
8. HANSEN HG, Gjode ICT, Starzer M, Ranning A, et al
   Clinical illness course and family-related outcomes among parents with a first episode of schizophrenia spectrum disorder: a 20-year follow-up of the OPUS trial.
   Psychol Med. 2024 Apr 2:1-10. doi: 10.1017/S0033291724000680.
   

   >> Share

   
   
9. JORGENSEN KN, Nerland S, Slapo NB, Norbom LB, et al
   Assessing regional intracortical myelination in schizophrenia spectrum and bipolar disorders using the optimized T1w/T2w-ratio.
   Psychol Med. 2024 Apr 2:1-11. doi: 10.1017/S0033291724000503.
   

   >> Share

   
   
10. HJORTHOJ C, Sturup A, Karlsen M, Speyer H, et al
    Use of antipsychotic medication, benzodiazepines, and psychiatric hospitalization in cannabis-related versus cannabis-unrelated schizophrenia - a nationwide, register-based cohort study.
    Psychol Med. 2024 Apr 4:1-10. doi: 10.1017/S0033291724000758.
    

    >> Share

    
    

    
    Schizophr Res

11. CEDERLOF E, Holm M, Taipale H, Tiihonen J, et al
    Antipsychotic medications and sleep problems in patients with schizophrenia.
    Schizophr Res. 2024;267:230-238.
    

    >> Share

    
    
12. VARDEN GJERDE K, Bartz-Johannessen C, Steen VM, Andreassen OA, et al
    Cellular adhesion molecules in drug-naive and previously medicated patients with schizophrenia-spectrum disorders.
    Schizophr Res. 2024;267:223-229.
    

    >> Share

    
    
13. BISMARK AW, Mikhael T, Mitchell K, Holden J, et al
    Pupillary responses as a biomarker of cognitive effort and the impact of task difficulty on reward processing in schizophrenia.
    Schizophr Res. 2024;267:216-222.
    

    >> Share

    
    
14. FRANCO-RUBIO L, Puente-Martinez A, Ubillos-Landa S
    Factors associated with recovery during schizophrenia and related disorders: A review of meta-analysis.
    Schizophr Res. 2024;267:201-212.
    

    >> Share

    
    
15. LI Y, Qiu D, Wu Q, Ni A, et al
    Affiliate stigma and its association with family burden among family members of people living with schizophrenia in China.
    Schizophr Res. 2024;267:193-200.
    

    >> Share

    
    
16. COHEN-LAROQUE J, Grangier I, Perez N, Kirschner M, et al
    Positive and negative symptoms in methamphetamine-induced psychosis compared to schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2024;267:182-190.
    

    >> Share

    
    
17. DODD K, Legget KT, Cornier MA, Novick AM, et al
    Relationship between functional connectivity and weight-gain risk of antipsychotics in schizophrenia.
    Schizophr Res. 2024;267:173-181.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share